Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial

BACKGROUND: Olanzapine is an inexpensive and durable agent for the treatment of chemotherapy‐induced nausea and vomiting and is also superior to neurokinin‐1 receptor antagonists in the control of nausea. This study aimed to investigate the efficacy and safety of a low dose of 5 mg olanzapine plus g...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Chizuru, Shimokawa, Mototsugu, Iihara, Hirotoshi, Fujita, Yukiyoshi, Ikemura, Shinnosuke, Hirose, Chiemi, Kotake, Mie, Funaguchi, Norihiko, Gomyo, Takenobu, Imai, Hisao, Hakamata, Jun, Kaito, Daizo, Minato, Koichi, Arai, Takahiro, Kawazoe, Hitoshi, Suzuki, Akio, Ohno, Yasushi, Okura, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Symptom Management and Supportive Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176968/
https://www.ncbi.nlm.nih.gov/pubmed/33811782
http://dx.doi.org/10.1002/onco.13772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176968/
https://www.ncbi.nlm.nih.gov/pubmed/33811782
http://dx.doi.org/10.1002/onco.13772

Ejemplares similares